Position in BIIB
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$534,748
+$69,090 QoQ
Shares Held
2,475
-2.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#566
of 1,036 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Aljian Capital Management, LLC holds $9,902,453 across 9 Drug Manufacturers - General names. BIIB ranks #8 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,811 | $2,172,167 | |
| 2 | AMGN |
Amgen Inc
|
5,648 | $2,045,253 | |
| 3 | ABBV |
AbbVie Inc.
|
7,024 | $1,767,519 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
17,011 | $980,173 | |
| 5 | JNJ |
Johnson & Johnson
|
3,400 | $863,498 | |
| 6 | MRK |
Merck & Co., Inc.
|
5,955 | $765,217 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
4,496 | $568,024 | |
| 8 | BIIB |
Biogen Inc.
This page
|
2,475 | $534,748 |
All Filings in BIIB
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $534,748 | 2,475 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $465,658 | 2,540 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $425,015 | 2,415 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $338,293 | 2,415 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $318,998 | 2,540 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $347,573 | 2,540 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $391,475 | 2,560 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $522,204 | 2,694 | Shares | Sole | 2024-11-07 | |
| No filing history on record for this holder in this stock. | ||||||